期刊文献+

依达拉奉治疗糖尿病周围神经病变的疗效观察 被引量:4

Therapy of Edaravone for Diabetic Peripheral Neuropathy
下载PDF
导出
摘要 目的观察依达拉奉治疗糖尿病周围神经病变(DPN)的疗效。方法将83例患者随机分为治疗组(41例)和对照组(42例),均在胰岛素强化降糖治疗基础上,治疗组给予依达拉奉与丹参,对照组给予甲钴胺与丹参治疗,连用2周后评估其疗效。结果治疗组DPN的症状、体征及神经传导速度改善明显高于对照组(P<0.01)。结论依达拉奉可明显改善DPN的治疗效果。 Objective To observe the effect of edaravone for diabetic peripheral neuropathy(DPN). Methods A total of 83 DPN cases were at random divided into treatment group(n=41) and control group(n=42). The treatment group was given edaravone and Danshen and the control group was given mecobalamin and Danshen,during which the control of blood sugar with insulin were performed simultaneously in the two group. At the end of a 2-week period, the therapeutic effect was evaluated. Results In the treatment group, the improvement of DPN symptoms and nervous conducting speed are much more obvious than that in control group(P〈0.01). Conclusion Edaravone can effectively better the therapeutic outcome of DPN.
出处 《中国现代医生》 2010年第4期156-157,共2页 China Modern Doctor
关键词 依达拉奉 糖尿病周围神经病变 氧化应激 Edaravone Diabetic peripheral neuropathy Oxidative stress
  • 相关文献

参考文献6

二级参考文献18

  • 1窦京涛,李江源,汪寅章,黄兆坚.人绒毛膜促性腺激素对大鼠睾丸相关激素受体的影响[J].中华医学杂志,1994,74(9):570-571. 被引量:7
  • 2刘嵋,张金辉.糖尿病性神经病变的药物治疗现状[J].中华内分泌代谢杂志,1996,12(1):37-39. 被引量:193
  • 3龚小花,郑景晨.氧化应激与糖尿病神经病变[J].国际内分泌代谢杂志,2006,26(B04):16-18. 被引量:37
  • 4钟惠菊 韩香云 方育川.PGE1治疗糖尿病神经病变临床观察[J].实用糖尿病杂志,1994,2(1):33-33.
  • 5Brownlee M.Biochemistry and molecular cell biology of diabetic complications.Nature,2001,414:813-820.
  • 6Vincent AM,Mclean LL,Backus C,et al.Shorterm hyperglycemia produces oxdative damage and apoptosis in neurons.FASEB J,2005,19:638-640.
  • 7Baydas G,Donder E,Kiliboz M,et al.Neuroprotection by α-lipoic acid in streptozotocin-induced diabetes.Biochemistry,2004,69:1001-1005.
  • 8Hirsh J,Levine MN.Lowmolecular weight heparin[J].Blood,1992,79:1-17.
  • 9Fareed J,Hoppensteadt SA.Pharmacolgy of lowmole cular-Weight heparin[J].Semin Thromb Hemost,1996,22Suppl,2:13-18.
  • 10 Carlson LA, OlssonAG. Intravenous prostaglandin E1 in severe peripheral vascular disease[J].Lancet, 1976, 9(7886)∶810

共引文献905

同被引文献28

  • 1付艳芹,张东铭,辛雅萍,张苏河.α-硫辛酸对糖尿病周围神经病变的疗效及对氧化应激的影响[J].中国实用神经疾病杂志,2010,13(23):70-71. 被引量:18
  • 2李检生,杨友松.新型自由基清除剂依达拉奉的脑保护作用[J].国际神经病学神经外科学杂志,2006,33(2):125-128. 被引量:107
  • 3柯涓,庄曼茹.依达拉奉与甲钴胺联合治疗糖尿病周围神经病变[J].中华神经医学杂志,2006,5(7):747-749. 被引量:15
  • 4Arri K,Kumon Y,Zkeda Y.Edaravone inhibits rheuratoid synovial cell prolifer-ation and mig-ration[J] ,Free Radic RES,2006,40(02):121-125.
  • 5Uno M,Kitazao KT,Suzue A,et al.Inhibition of brian damage by edaravone,a free radical scav-enger,can be monitored by plasma biomarkers that detect oxidative and astrocyte damage in patients with acute cerebral infarction[J].Free Radical Biology and Medicine,2005,39(8):1109-1116.
  • 6Mishina U,Komaba Y,Kobayashis,et al.Efficacy of edaravone,a free radical scavenger,for the treatment of acute lacunars infarction[J] ,Neural Medchir(Tokyo),2005,45(7):344-348.
  • 7Hayashi,Mori T,Sohmiya K,et al.Efficacy of Edaravone,a Free Radical Scavenger,on Left Ventricular Function and Structure in Diabetes Mellitus[J].Cardiovasc Pharmacol,2003,41 (6):923-929.
  • 8贺纯静,余倩,梁代义,冯亚平,韦阿琛,冉艳.星状神经节阻滞对特发性面神经麻痹患者红细胞免疫功能的影响[J].临床麻醉学杂志,2007,23(8):640-642. 被引量:6
  • 9Cavender MA, Linco{f AM. Therapeutic potential of aleglitazar, a new dual PPAR-alpha/gamma agonist: implications for cardiovascular disease in patients with diabetes mellitus[J]. American Journal of Cardiovas- cular Drugs,2010,10(4) : 209-216.
  • 10Jin DM,Xu Y, Geng DF, et al. Effect of transeutaneous electrical nerve stimulation on symptomatic diabetic pe- ripheral neuropathy., a meta-analysis of randomized controlled trials[J]. Diabetes Res Clin Praet, 2010,89 (1) .. 10-15.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部